Improvement of bone marrow hematopoiesis in idiopathic myelofibrosis with prednisolone

Ryuji Tanosaki, H. Uchida, Y. Masuda, N. Michikawa, T. Ogawa, A. Kubo, Y. Ikeda

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

A 64 year-old female patient of idiopathic myelofibrosis (IMF), who had had rapidly progressing massive splenomegaly and severe pancytopenia refractory to blood transfusion, was treated with PSL 0.6 mg/kg/day for a month, being significantly improved not only symptomatically and hematologically but also in bone marrow hematopoiesis. Although the effectiveness of PSL to restoration of bone marrow hematopoiesis has been almost unknown, long term oral PSL should be tried for a certain phase of IMF.

Original languageEnglish
Pages (from-to)256-258
Number of pages3
Journal[Rinsho ketsueki] The Japanese journal of clinical hematology
Volume33
Issue number2
Publication statusPublished - 1992 Feb

Fingerprint

Primary Myelofibrosis
Hematopoiesis
Prednisolone
Bone Marrow
Pancytopenia
Splenomegaly
Blood Transfusion

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Improvement of bone marrow hematopoiesis in idiopathic myelofibrosis with prednisolone. / Tanosaki, Ryuji; Uchida, H.; Masuda, Y.; Michikawa, N.; Ogawa, T.; Kubo, A.; Ikeda, Y.

In: [Rinsho ketsueki] The Japanese journal of clinical hematology, Vol. 33, No. 2, 02.1992, p. 256-258.

Research output: Contribution to journalArticle

Tanosaki, R, Uchida, H, Masuda, Y, Michikawa, N, Ogawa, T, Kubo, A & Ikeda, Y 1992, 'Improvement of bone marrow hematopoiesis in idiopathic myelofibrosis with prednisolone', [Rinsho ketsueki] The Japanese journal of clinical hematology, vol. 33, no. 2, pp. 256-258.
Tanosaki, Ryuji ; Uchida, H. ; Masuda, Y. ; Michikawa, N. ; Ogawa, T. ; Kubo, A. ; Ikeda, Y. / Improvement of bone marrow hematopoiesis in idiopathic myelofibrosis with prednisolone. In: [Rinsho ketsueki] The Japanese journal of clinical hematology. 1992 ; Vol. 33, No. 2. pp. 256-258.
@article{9f4a43496bd04837b9f3c10988ec36c6,
title = "Improvement of bone marrow hematopoiesis in idiopathic myelofibrosis with prednisolone",
abstract = "A 64 year-old female patient of idiopathic myelofibrosis (IMF), who had had rapidly progressing massive splenomegaly and severe pancytopenia refractory to blood transfusion, was treated with PSL 0.6 mg/kg/day for a month, being significantly improved not only symptomatically and hematologically but also in bone marrow hematopoiesis. Although the effectiveness of PSL to restoration of bone marrow hematopoiesis has been almost unknown, long term oral PSL should be tried for a certain phase of IMF.",
author = "Ryuji Tanosaki and H. Uchida and Y. Masuda and N. Michikawa and T. Ogawa and A. Kubo and Y. Ikeda",
year = "1992",
month = "2",
language = "English",
volume = "33",
pages = "256--258",
journal = "[Rinshō ketsueki] The Japanese journal of clinical hematology",
issn = "0485-1439",
publisher = "Nihon Rinsho Ketsueki Gakkai/Japan Society of Clinical Hematology",
number = "2",

}

TY - JOUR

T1 - Improvement of bone marrow hematopoiesis in idiopathic myelofibrosis with prednisolone

AU - Tanosaki, Ryuji

AU - Uchida, H.

AU - Masuda, Y.

AU - Michikawa, N.

AU - Ogawa, T.

AU - Kubo, A.

AU - Ikeda, Y.

PY - 1992/2

Y1 - 1992/2

N2 - A 64 year-old female patient of idiopathic myelofibrosis (IMF), who had had rapidly progressing massive splenomegaly and severe pancytopenia refractory to blood transfusion, was treated with PSL 0.6 mg/kg/day for a month, being significantly improved not only symptomatically and hematologically but also in bone marrow hematopoiesis. Although the effectiveness of PSL to restoration of bone marrow hematopoiesis has been almost unknown, long term oral PSL should be tried for a certain phase of IMF.

AB - A 64 year-old female patient of idiopathic myelofibrosis (IMF), who had had rapidly progressing massive splenomegaly and severe pancytopenia refractory to blood transfusion, was treated with PSL 0.6 mg/kg/day for a month, being significantly improved not only symptomatically and hematologically but also in bone marrow hematopoiesis. Although the effectiveness of PSL to restoration of bone marrow hematopoiesis has been almost unknown, long term oral PSL should be tried for a certain phase of IMF.

UR - http://www.scopus.com/inward/record.url?scp=0026816322&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026816322&partnerID=8YFLogxK

M3 - Article

VL - 33

SP - 256

EP - 258

JO - [Rinshō ketsueki] The Japanese journal of clinical hematology

JF - [Rinshō ketsueki] The Japanese journal of clinical hematology

SN - 0485-1439

IS - 2

ER -